Shares of FiscalNote Holdings slipped to $0.06 on August 31, extending a penny-stock slide that has erased virtually all shareholder value, after the company confirmed it sold its FrontierView advisory unit and cut full-year guidance to match. FiscalNote Sells Off Another Piece of Itself to Focus on Policy Data, but Can a Shrinking Company Outrun Its Own Decline?
Shares slipped to $0.06 — down 8.3% — as FiscalNote completed yet another divestiture and slashed its 2026 outlook for the second time in three weeks, raising a blunt question: is this strategic simplification or managed liquidation?
The Revenue Bar Keeps Dropping
FiscalNote updated its full-year 2026 guidance issued on August 10 to remove FrontierView's contribution, now expecting revenue of $74–$76 million and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization — essentially operating profit before accounting charges) of $8–$10 million. Context matters: the company started 2026 guiding for $80–$83 million in revenue and $14–$16 million in adjusted EBITDA.
By Q2 earnings in August, that had already been cut to $75–$78 million and $9–$11 million due to federal spending softness and cautious corporate customers. Two guidance reductions in rapid succession signal a business still searching for a floor.
Selling FrontierView Shrinks the Problem — and the Company
FiscalNote sold FrontierView, its market intelligence unit, to Oxford Economics, framing the deal as sharpening focus on its core policy and regulatory intelligence platform while simplifying operations and strengthening the balance sheet. But the company didn't disclose a sale price, making it impossible to judge whether shareholders received fair value. FiscalNote has already written down $35.6 million in goodwill in Q1 and
another $19.1 million in Q2, producing a GAAP net loss of $27.8 million last quarter alone. Selling units after massive impairments often means the price was modest.
The Core Business Isn't Growing Either
Management insists the guidance cut "does not represent any change in the Company's expectations for its core Policy business." Yet Q2 revenue fell 16% year-over-year to $19.6 million, and Q1 revenue was down 27%.
Net revenue retention — how much existing customers spend versus the prior year — improved to 98% from 89% in Q1, a positive sign but still below the 100% threshold needed to stop the revenue slide from existing accounts.
What's Left to Sell, and Who's Left to Buy?
FiscalNote already sold Oxford Analytica and Dragonfly Intelligence to Dow Jones for $40 million earlier.
The company has cut roughly 25% of its workforce this year and is targeting positive free cash flow by Q1 2027. At a $0.06 share price, the stock now trades on OTC markets — far from its NYSE listing days — and the market is assigning negligible value to whatever remains. The divestitures may be rational, but investors need to see growth from the slimmed-down core, not just more subtraction.